CeriBell Inc (NAS:CBLL)
$ 18.61 +0.22 (+1.2%) Market Cap: 706.11 Mil Enterprise Value: 587.08 Mil PE Ratio: 0 PB Ratio: 5.01 GF Score: 12/100

Ceribell Inc at JPMorgan Healthcare Conference Transcript

Jan 12, 2026 / 05:00 PM GMT
Release Date Price: $23.43 (+0.43%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CBLL.OQ - CeriBell Inc
Ceribell Inc at JPMorgan Healthcare Conference
Jan 12, 2026 / 05:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning everyone. I'm Robbie Marcus, the Medtech analyst at JP Morgan. Very happy to introduce our next company, Cerebell. We'll have Jane Chow, the CEO, come up for a presentation, followed by some Q&A. Jane.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, Robbie. Good morning, everyone.

I'm very excited to share with you the overview of Cerebell and our 2025 accomplishment and 2026 plan.

So, at the highest level, Cereba has developed a platform for neuro monitoring.

It has the hardware that makes EEG or brain wave acquisition really
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot